- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
March 4th, 2005
When companies partner with one another, it is with the expectation that each has a role to play. Each is expected to perform its part conscientiously and expeditiously. When one partner doesn't hold up its end of the bargain, it results in delays, lost opportunities and, most importantly for companies, lost revenues.
Such is the case with the just-severed deal between pharmaceutical Biovail and nanotech developer Flamel.
|Related News Press|
Nanometrics to Participate in the Citi 2015 Global Technology Conference August 26th, 2015
Successful boron-doping of graphene nanoribbon August 27th, 2015
Nanolab Technologies LEAPS Forward with High-Performance Analysis Services to the World: Nanolab Orders Advanced Local Electrode Atom Probe (LEAP®) Microscope from CAMECA Unit of AMETEK Materials Analysis Division August 27th, 2015